Helicobacter Pylori (H. Pylori) IgG ELISA Kit
- 貨號 Cat. No.
- BQ 013G
- 規格 Size
- 96 Well Plate
- 品牌 Brand
- BIOQUANT
Description
The Helicobacter pylori (H. Pylori) IgG ELISA test system is an enzyme-linked immunosorbent assay (ELISA) for the detection of IgG class antibodies to Helicobacter pylori (H. Pylori)) in human serum or plasma. H. pylori is detectable in nearly 100% of adult patients with duodenal ulcer and about 80% of patients with gastric ulcer. There is excellent correlation between the clinical presentation of gastritis, the presence of H. pylori in the stomach and elevated serum H. pylori IgG and IgA antibodies. ELISA sensitivity and specificity are 90%, and the predictive value of a negative result is very high. H. pylori IgG and/or IgA antibodies falls significantly after successful antibacterial therapy. Eradication of H. pylori is associated with a significant reduction in duodenal ulcer recurrence. H. pylori strains are classified into two broad groups - those that express both VacA and CagA (type I) and those that produce neither (type II). Type I strains are predominate in patients with ulcers and cancer. Up to 50% of adults is infected with H. pylori, but most of them are asymptotic and will not develop ulcer. The reason is they are infected with type II. 80-100% of patients with duodenal ulcer disease produce CagA antibodies against a 128 kd antigen compared with 60-63% of H. pylori-infected persons with gastritis only, indicating that serologic responses to the 128 kd protein are more prevalent among H. pylori-infected persons with duodenal ulcers than infected persons without peptic ulceration. In H. pylori-infected patients who develop gastric cancer, serum IgG against CagA 94% sensitive and 93% specific, indicating that detection of antibodies to CagA is useful marker for diagnosis of duodenal ulcer and gastric cancer.
同品牌其他產品